A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke. (December 2020)

• Record Type: Journal Article
• Authors: Cappellari, Manuel; Seiffge, David J; Koga, Masatoshi; Paciaroni, Maurizio; Forlivesi, Stefano; Turcato, Gianni; Bovi, Paolo; Yoshimura, Sohei; Tanaka, Kanta; Shiozawa, Masayuki; Yoshimoto, Takeshi; Miwa, Kaori; Takagi, Masahito; Inoue, Manabu; Yamagami, Hiroshi; Caso, Valeria; Tsivgoulis, Georgios; Venti, Michele; Acciarresi, Monica; Alberti, Andrea; Toni, Danilo; Polymeris, Alexandros; Bonetti, Bruno; Agnelli, Giancarlo; Toyoda, Kazunori; Engelter, Stefan T; Marchis, Gian Marco De
• Is Part Of: European stroke journal. Volume 5:Number 4(2020)
• Page Start: 384
• Page End: 393
• Publication Date: 2020-12
• Subjects: Stroke -- atrial fibrillation -- direct oral anticoagulant -- vitamin K antagonist -- outcome -- nomogram; Cerebrovascular disease -- Periodicals; 616.8005
• DOI: 10.1177/2396987320945840
• Languages: English
• ISSNs: 2396-9873

Abstract

Introduction: It is unknown whether the type of treatment (direct oral anticoagulant versus vitamin K antagonist) and the time of treatment introduction (early versus late) may affect the functional outcome in stroke patients with atrial fibrillation. We aimed to develop and validate a nomogram model including direct oral anticoagulant/vitamin K antagonist and early/late oral anticoagulant introduction for predicting the probability of unfavourable outcome after stroke in atrial fibrillation-patients. Patients and Methods: We conducted an individual patient data analysis of four prospective studies. Unfavourable functional outcome was defined as three-month modified Rankin Scale score 3 -6. To generate the nomogram, five independent predictors including age (<65 years, reference; 65--79; or 80), National Institutes of Health Stroke Scale score (0--5 points, reference; 6--15; 16--25; or >25), acute revascularisation treatments (yes, reference, or no), direct oral anticoagulant (reference) or vitamin K antagonist, and early (7 days, reference) or late (8--30) anticoagulant introduction entered into a final logistic regression model. The discriminative performance of the model was assessed by using the area under the receiver operating characteristic curve. Results: A total of 2102 patients with complete data for generating the nomogram was randomly dichotomised into training ( n = 1553) and test ( n = 549) sets. The area under the receiver operating characteristic curve was 0.822 (95% confidence interval, CI: 0.800--0.844) in the training set and 0.803 (95% CI: 0.764--0.842) in the test set. The model was adequately calibrated (9.852; p = 0.276 for the Hosmer--Lemeshow test). Discussion and Conclusion: Our nomogram is the first model including type of oral anticoagulant and time of treatment introduction to predict the probability of three-month unfavourable outcome in a large multicentre cohort of stroke patients with atrial fibrillation.